Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down1.35% Nasdaq Down1.12%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS

231.38 Down 11.38(4.69%) Jun 19, 4:00PM EDT|After Hours : 231.38 0.00 (0.00%) Jun 19, 4:32PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 1,378,477   445,824   459,074  
Cost of Revenue84,455  4,216  2,093  
Gross Profit 1,294,022   441,608   456,981  
Operating Expenses
Research Development625,554  529,506  489,252  
Selling General and Administrative210,755  117,261  65,201  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 457,713   (205,159) (97,472)
Income from Continuing Operations
Total Other Income/Expenses Net2,012  3,549  2,122  
Earnings Before Interest And Taxes459,725  (201,610)(95,350)
Interest Expense45,304  21,282  9,118  
Income Before Tax414,421  (222,892)(104,468)
Income Tax Expense(335,848)(1,132) -  
Minority Interest -   -   -  
Net Income From Continuing Ops750,269  (221,760)(104,468)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 750,269   (221,760) (104,468)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 750,269   (221,760) (104,468)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.